IDL Biotech: Out-licensing of IRMA products
Research Note
2019-10-02
14:28
IDL biotech today announced a license agreement with Beckman Coulter Diagnostics regarding its lab-based IRMA products. Today’s news will not have any an impact on our valuation.
LS
Ludvig Svensson
Disclosures and disclaimers